Roche announces EMA committee recommends EU label update for its Phesgo to allow administration outside of clinical settings: Basel Friday, May 2, 2025, 12:00 Hrs [IST] Roche anno ...

Mersana Therapeutics, Inc.’s MRSN share price has dipped by 8.13%, which has investors questioning if this is right time to ...

A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

A post hoc analysis shows significantly improved ORR and PFS in advanced NSCLC with higher AFM24 exposure, supporting ...